OptiNose Analyst Ratings
OptiNose Analyst Ratings
While ratings are subjective and will change, the latest OptiNose (OPTN) rating was a initiated with a price target of $0.00 to $3.00. The current price OptiNose (OPTN) is trading at is $1.30, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/21/2023 | 130.77% | Lake Street | → $3 | Initiates Coverage On | → Buy |
| 08/11/2023 | 130.77% | Piper Sandler | $4 → $3 | Maintains | Overweight |
| 11/14/2022 | 284.62% | BMO Capital | $6 → $5 | Maintains | Outperform |
| 10/21/2022 | 284.62% | Jefferies | → $5 | Assumes | → Buy |
| 03/05/2020 | 1515.38% | Cantor Fitzgerald | $27 → $21 | Reiterates | → Overweight |
| 12/18/2019 | 1823.08% | Cowen & Co. | → $25 | Initiates Coverage On | → Outperform |
| 08/13/2019 | 1746.15% | BMO Capital | $26 → $24 | Maintains | Outperform |
| 11/14/2018 | 1976.92% | Cantor Fitzgerald | $30 → $27 | Maintains | Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月21日 | 130.77% | 萊克街 | →$3 | 開始承保 | →購買 |
| 2023年08月11日 | 130.77% | 派珀·桑德勒 | $4→$3 | 維護 | 超重 |
| 2022年11月14日 | 284.62% | 蒙特利爾銀行資本 | $6→$5 | 維護 | 跑贏大盤 |
| 2022年10月21日 | 284.62% | 傑富瑞 | →$5 | 假設 | →購買 |
| 03/05/2020 | 1515.38% | 康託·菲茨傑拉德 | $27→$21 | 重申 | →超重 |
| 2019年12月18日 | 1823.08% | 考恩公司 | →$25 | 開始承保 | →跑贏大盤 |
| 2019年08月13日 | 1746.15% | 蒙特利爾銀行資本 | $26→$24 | 維護 | 跑贏大盤 |
| 2018年11月14日 | 1976.92% | 康託·菲茨傑拉德 | $30→$27 | 維護 | 超重 |
What is the target price for OptiNose (OPTN)?
OptiNose的目標價是多少？
The latest price target for OptiNose (NASDAQ: OPTN) was reported by Lake Street on August 21, 2023. The analyst firm set a price target for $3.00 expecting OPTN to rise to within 12 months (a possible 130.77% upside). 4 analyst firms have reported ratings in the last year.
湖街於2023年8月21日報道了OptiNose(納斯達克：OPTN)的最新目標價。這家分析公司將目標價定為3美元，預計OPTN將在12個月內上漲至(可能上漲130.77%)。去年有4家分析公司公佈了評級。
What is the most recent analyst rating for OptiNose (OPTN)?
分析師對OptiNose的最新評級是多少？
The latest analyst rating for OptiNose (NASDAQ: OPTN) was provided by Lake Street, and OptiNose initiated their buy rating.
OptiNose(納斯達克代碼：OPTN)的最新分析師評級是由Lake Street提供的，OptiNose啟動了他們的買入評級。
When is the next analyst rating going to be posted or updated for OptiNose (OPTN)?
OptiNose(OPTN)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OptiNose, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OptiNose was filed on August 21, 2023 so you should expect the next rating to be made available sometime around August 21, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與OptiNose的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。OptiNose的上一次評級是在2023年8月21日提交的，因此您應該預計下一次評級將在2024年8月21日左右提供。
Is the Analyst Rating OptiNose (OPTN) correct?
分析師評級OptiNose(OPTN)正確嗎？
While ratings are subjective and will change, the latest OptiNose (OPTN) rating was a initiated with a price target of $0.00 to $3.00. The current price OptiNose (OPTN) is trading at is $1.30, which is within the analyst's predicted range.
雖然評級是主觀的，而且會發生變化，但最新的OptiNose(OPTN)評級是以0.00美元至3.00美元的目標價啟動的。OptiNose目前的交易價格為1.30美元，在分析師的預測範圍內。
